Biomx inc. (CHAC)
CashFlow / Yearly
Dec'19Jun'19Dec'18
CASH FLOWS - OPERATING ACTIVITIES
Net Loss

-20,563

347

-12,720

Adjustments required to reconcile cash flows used in operating activities:
Depreciation and amortization

318

-

210

Share-based payment

938

-

951

Revaluation of contingent liabilities

304

-

112

Interest income on marketable securities held in Trust Account

-

886

-

Unrealized loss on marketable securities held in Trust Account

-

-5

-

Deferred tax provision

-

-1

-

Changes in operating assets and liabilities:
Other current assets

1,845

-

-187

Prepaid expenses and other current assets

-

39

-

Trade account payables

3,060

233

-228

Other account payables

836

-

358

Operating lease liabilities

-83

-

-

Related parties

-100

-

50

Income taxes payable

-

136

-

Net cash used in operating activities

-17,577

-204

-11,304

CASH FLOWS - INVESTING ACTIVITIES
Decrease in short-term deposit

21,052

-

-29,901

Purchase of property and equipment

1,312

-

137

Cash withdrawn from Trust Account to pay for income taxes

-

70,000

-

Net cash used in investing activities

19,740

-70,000

-30,038

CASH FLOWS - FINANCING ACTIVITIES
Issuance of preferred shares, net of issuance costs

1,800

-

43,042

Cash acquired in connection with the reverse recapitalization transaction, net

59,673

-

-

Acquisition of treasury stock

19

-

-

Exercise of stock options

100

-

-

Proceeds from sale of Units, net of underwriting discounts paid

-

69,500

-

Proceeds from sale of Private Placement Warrants

-

1,160

-

Proceeds from promissory notes - related party

-

565

-

Repayment of promissory note - related party

-

105

-

Payment of offering costs

-

219

-

Net cash provided by financing activities

61,554

70,900

43,042

Decrease in cash and cash equivalents and restricted cash

63,717

-

1,700

Supplemental non-cash transactions:
Recognition of right-of-use asset and lease liability upon adoption of ASU 2016-02

662

-

-

Assets acquired under operating leases

690

-

-

Assets acquired (liabilities assumed) in reverse recapitalization transaction:
Current assets (excluding cash and cash equivalents)

-88

-

-

Current liabilities

364

-

-

Reverse recapitalization effect on equity

59,397

-

-

Cash acquired in connection with reverse recapitalization transaction

59,673

-

-

Net Change in Cash and Cash Equivalents

-

696

-

Change in value of common stock subject to redemption

-

65,399

-

Offering costs included in accrued offering costs

-

348

-